Every Prednisone Prescription Has a Receipt

A clinical brief for referring providers — week 3 of a 4-part series on severe and difficult-to-control asthma.

Quick question before you read on: Among all complications of chronic oral corticosteroid use, which carries the highest hazard ratio?

a) Type 2 diabetes b) Fracture c) Adrenal insufficiency

Oral corticosteroids remain the most reliable short-term tool we have in asthma. They are also the reason many of these patients should be referred sooner than they are.

The toxicity is dose-dependent and cumulative, and it begins lower than most of us assume — at prednisolone doses as low as 2.5–7.5 mg/day.

A Danish nationwide study of 30,352 OCS users found increased risk of all studied complications, with a clear dose-response relationship starting at a cumulative dose of 500 mg prednisolone equivalent or less, and increased mortality with increasing exposure.

500 mg cumulative prednisolone equivalent is where the dose-response begins. That is not a career of steroid use — it is a handful of bursts.

What the cohort found

Adrenal insufficiency: HR 8.53 — highest of all complications

Severe infection: OR 2.16 with current use

Fracture: HR 1.24 even at cumulative doses of 500 mg or less

Type 2 diabetes: OR 1.21–1.44 with 4 or more prescriptions per year

Psychiatric: Highest incidence rate difference — 4.3 per 1,000 person-years

This is what makes biologics worth the referral. OCS-sparing evidence is strongest for mepolizumab (50% median dose reduction), benralizumab (75% versus 25% placebo in ZONDA), and dupilumab (70% versus 42% placebo). Tezepelumab did not demonstrate an OCS-sparing effect in the SOURCE trial.

Three things that help before referral

Optimize ICS delivery and confirm technique before adding OCS.

Consider adding a LAMA — tiotropium as add-on may improve control enough to avoid steroids.

Treat the comorbidities that drive poor control.

And a caution: never taper abruptly. Patients on chronic OCS require a structured taper and assessment for adrenal insufficiency.

Want the OCS-sparing evidence walked through with your team?

Dr. Joel Mensing of the Chest & Sleep Team runs a 20-minute clinical briefing covering cumulative steroid burden, which biologics carry the strongest OCS-sparing data, and how a structured taper is run safely. Lunch provided. No pitch — just the clinical walkthrough.

Call (847) 860-7250.

The answer

Adrenal insufficiency, HR 8.53 — the highest of all studied complications.